Advertisement

  • Loading metrics

Open Access

Correction

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

  • Lieselotte Vande Walle,
  • Irma B. Stowe,
  • Pavel Šácha,
  • Bettina L. Lee,
  • Dieter Demon,
  • Amelie Fossoul,
  • Filip Van Hauwermeiren,
  • Pedro H. V. Saavedra,
  • Petr Šimon,
  • Vladimír Šubr,
  • Libor Kostka,
  • Craig E. Stivala,
  • Victoria C. Pham,
  • Steven T. Staben,
  • Sayumi Yamazoe,
  • Jan Konvalinka,
  • Nobuhiko Kayagaki,
  •  [ ... ],
  • Mohamed Lamkanfi
  • [ view all ]
  • [ view less ]

The tenth author's name is spelled incorrectly. The correct name is: Vladimír Šubr.

Reference

  1. 1. Vande Walle L, Stowe IB, Šácha P, Lee BL, Demon D, Fossoul A, et al. (2019) MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. PLoS Biol 17(9): e3000354. https://doi.org/10.1371/journal.pbio.3000354 pmid:31525186

Citation: Walle LV, Stowe IB, Šácha P, Lee BL, Demon D, Fossoul A, et al. (2019) Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. PLoS Biol 17(10): e3000529. https://doi.org/10.1371/journal.pbio.3000529

Published: October 16, 2019

Copyright: © 2019 Walle et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.